These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17296911)

  • 1. Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: implications for treatment.
    Pittock SJ
    Neurology; 2007 Feb; 68(7):480-1. PubMed ID: 17296911
    [No Abstract]   [Full Text] [Related]  

  • 2. Age at disability milestones in multiple sclerosis and history of multiple sclerosis: a unifying concept.
    Goodin D
    Brain; 2006 Dec; 129(Pt 12):e56; author reply e57. PubMed ID: 17132635
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse, remission, and progression in multiple sclerosis.
    McDonald WI
    N Engl J Med; 2000 Nov; 343(20):1486-7. PubMed ID: 11078776
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
    D'Souza M; Kappos L; Czaplinski A
    J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conclusion].
    Vermersch P
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S180-1. PubMed ID: 19361685
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis.
    Cohen BA
    Neurology; 2008 Dec; 71(24 Suppl 3):S14-20. PubMed ID: 19064870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].
    Saiz A; Blanco Y; Berenguer J; Gómez-Choco M; Carreras E; Arbizu T; Graus F
    Neurologia; 2008 Sep; 23(7):405-7. PubMed ID: 18726717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at onset determines the occurrence of the progressive phase of multiple sclerosis.
    Stankoff B; Mrejen S; Tourbah A; Fontaine B; Lyon-Caen O; Lubetzki C; Rosenheim M
    Neurology; 2007 Mar; 68(10):779-81. PubMed ID: 17339588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history of multiple sclerosis: the changing frame of the disease over the centuries.
    Murray TJ
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S3-8. PubMed ID: 19200863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early multiple sclerosis: to treat or not to treat?
    Roach ES
    Arch Neurol; 2006 Apr; 63(4):619. PubMed ID: 16606782
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multiple sclerosis. Old observations, new hypotheses, future perspectives].
    Correale J
    Medicina (B Aires); 2005; 65(2):175-80. PubMed ID: 16075817
    [No Abstract]   [Full Text] [Related]  

  • 14. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis.
    Campion K
    Prof Nurse; 1997 Dec; 13(3):169-72. PubMed ID: 9439229
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the course and outcomes of multiple sclerosis is statistical twaddle--Yes.
    Taylor BV
    Mult Scler; 2016 Feb; 22(2):140-2. PubMed ID: 26830393
    [No Abstract]   [Full Text] [Related]  

  • 18. Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis.
    Motl RW; Arnett PA; Smith MM; Barwick FH; Ahlstrom B; Stover EJ
    Mult Scler; 2008 Jan; 14(1):140-2. PubMed ID: 18089672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and progression in multiple sclerosis.
    Koch M; van Harten A; Uyttenboogaart M; De Keyser J
    Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple sclerosis. Current aspects of the disease and treatment].
    Maschke M; Limmroth V
    Med Monatsschr Pharm; 2003 Dec; 26(12):404-8; quiz 409-10. PubMed ID: 14699776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.